166 related articles for article (PubMed ID: 33570803)
21. Comparison of serum tumor markers for intrahepatic cholangiocarcinoma and hepatocellular carcinoma.
Tao LY; Cai L; He XD; Liu W; Qu Q
Am Surg; 2010 Nov; 76(11):1210-3. PubMed ID: 21140686
[TBL] [Abstract][Full Text] [Related]
22. Precision N-glycoproteomics reveals elevated LacdiNAc as a novel signature of intrahepatic cholangiocarcinoma.
Li J; Zhao T; Li J; Shen J; Jia L; Zhu B; Dang L; Ma C; Liu D; Mu F; Hu L; Sun S
Mol Oncol; 2022 Jun; 16(11):2135-2152. PubMed ID: 34855283
[TBL] [Abstract][Full Text] [Related]
23. Intrahepatic cholangiocarcinoma with increased serum CYFRA 21-1 level.
Kashihara T; Ohki A; Kobayashi T; Sato T; Nishizawa H; Ogawa K; Tako H; Kawakami F; Tsuji M; Tamaoka K
J Gastroenterol; 1998 Jun; 33(3):447-53. PubMed ID: 9658330
[TBL] [Abstract][Full Text] [Related]
24. Serum Metabolites as Diagnostic Biomarkers for Cholangiocarcinoma, Hepatocellular Carcinoma, and Primary Sclerosing Cholangitis.
Banales JM; Iñarrairaegui M; Arbelaiz A; Milkiewicz P; Muntané J; Muñoz-Bellvis L; La Casta A; Gonzalez LM; Arretxe E; Alonso C; Martínez-Arranz I; Lapitz A; Santos-Laso A; Avila MA; Martínez-Chantar ML; Bujanda L; Marin JJG; Sangro B; Macias RIR
Hepatology; 2019 Aug; 70(2):547-562. PubMed ID: 30325540
[TBL] [Abstract][Full Text] [Related]
25. SMARCB1/INI1 Is Diagnostically Useful in Distinguishing α-Fetoprotein-producing Gastric Carcinoma from Hepatocellular Carcinoma.
Mochizuki K; Kawai M; Odate T; Tahara I; Inoue T; Kasai K; Nakazawa T; Kondo T
Anticancer Res; 2018 Dec; 38(12):6865-6868. PubMed ID: 30504402
[TBL] [Abstract][Full Text] [Related]
26. Diagnostic role of serum glypican-3 in differentiating hepatocellular carcinoma from non-malignant chronic liver disease and other liver cancers.
Tangkijvanich P; Chanmee T; Komtong S; Mahachai V; Wisedopas N; Pothacharoen P; Kongtawelert P
J Gastroenterol Hepatol; 2010 Jan; 25(1):129-37. PubMed ID: 19793164
[TBL] [Abstract][Full Text] [Related]
27. Biomarkers of intrahepatic cholangiocarcinoma: diagnosis and response to therapy.
Brown ZJ; Hewitt DB; Pawlik TM
Front Biosci (Landmark Ed); 2022 Mar; 27(3):85. PubMed ID: 35345317
[TBL] [Abstract][Full Text] [Related]
28. Small intrahepatic mass-forming cholangiocarcinoma: target sign on diffusion-weighted imaging for differentiation from hepatocellular carcinoma.
Park HJ; Kim YK; Park MJ; Lee WJ
Abdom Imaging; 2013 Aug; 38(4):793-801. PubMed ID: 22829097
[TBL] [Abstract][Full Text] [Related]
29. Distinguishing intrahepatic cholangiocarcinoma from hepatocellular carcinoma in patients with and without risks: the evaluation of the LR-M criteria of contrast-enhanced ultrasound liver imaging reporting and data system version 2017.
Li F; Li Q; Liu Y; Han J; Zheng W; Huang Y; Zheng X; Cao L; Zhou JH
Eur Radiol; 2020 Jan; 30(1):461-470. PubMed ID: 31297632
[TBL] [Abstract][Full Text] [Related]
30. Heterochronous development of intrahepatic cholangiocellular carcinoma following hepatocellular carcinoma in a hepatitis B virus carrier.
Shiozawa K; Ishii K; Mori T; Takamura N; Ikehara T; Shinohara M; Kawafune T; Sumino Y; Nonaka H
Intern Med; 2001 Jul; 40(7):624-30. PubMed ID: 11506304
[TBL] [Abstract][Full Text] [Related]
31. [CT and MR imaging differences between intrahepatic cholangiocarcinoma and hepatocellular carcinoma with invasions to billary tracts].
Yang NJ; Song B; Wu B; Xu J; Zhao LM
Sichuan Da Xue Xue Bao Yi Xue Ban; 2009 May; 40(3):525-8. PubMed ID: 19627020
[TBL] [Abstract][Full Text] [Related]
32. Canalicular immunostaining of aminopeptidase N (CD13) as a diagnostic marker for hepatocellular carcinoma.
Röcken C; Licht J; Roessner A; Carl-McGrath S
J Clin Pathol; 2005 Oct; 58(10):1069-75. PubMed ID: 16189153
[TBL] [Abstract][Full Text] [Related]
33. Urinary Metabolites Diagnostic and Prognostic of Intrahepatic Cholangiocarcinoma.
Haznadar M; Diehl CM; Parker AL; Krausz KW; Bowman ED; Rabibhadana S; Forgues M; Bhudhisawasdi V; Gonzalez FJ; Mahidol C; Budhu A; Wang XW; Ruchirawat M; Harris CC
Cancer Epidemiol Biomarkers Prev; 2019 Oct; 28(10):1704-1711. PubMed ID: 31358519
[TBL] [Abstract][Full Text] [Related]
34. Application of Joint Detection of AFP, CA19-9, CA125 and CEA in Identification and Diagnosis of Cholangiocarcinoma.
Li Y; Li DJ; Chen J; Liu W; Li JW; Jiang P; Zhao X; Guo F; Li XW; Wang SG
Asian Pac J Cancer Prev; 2015; 16(8):3451-5. PubMed ID: 25921161
[TBL] [Abstract][Full Text] [Related]
35. Diagnostic value of serum glypican-3 alone and in combination with AFP as an aid in the diagnosis of liver cancer.
Liu S; Wang M; Zheng C; Zhong Q; Shi Y; Han X
Clin Biochem; 2020 May; 79():54-60. PubMed ID: 32087138
[TBL] [Abstract][Full Text] [Related]
36. [The analysis of long-term prognostic factors after laparoscopic liver resection for intrahepatic cholangiocarcinoma and establishment of survival Nomogram model].
Shen ZF; Chen C; Geng ZM; Mao XH; Li JD; Song TQ; Sun CD; Wu H; Cheng ZJ; Lin RX; He Y; Zhai WL; Tang D; Tang ZH; Liang X
Zhonghua Wai Ke Za Zhi; 2022 Oct; 60(10):939-947. PubMed ID: 36207983
[No Abstract] [Full Text] [Related]
37. Synchronous double cancers of primary hepatocellular carcinoma and intrahepatic cholangiocarcinoma: a case report and review of the literature.
Wu C; Bai DS; Jiang GQ; Jin SJ
World J Surg Oncol; 2014 Nov; 12():337. PubMed ID: 25385169
[TBL] [Abstract][Full Text] [Related]
38. Analysis of N-linked Glycan Alterations in Tissue and Serum Reveals Promising Biomarkers for Intrahepatic Cholangiocarcinoma.
Ochoa-Rios S; Blaschke CRK; Wang M; Peterson KD; DelaCourt A; Grauzam SE; Lewin D; Angel P; Roberts LR; Drake R; Mehta AS
Cancer Res Commun; 2023 Mar; 3(3):383-394. PubMed ID: 36890858
[TBL] [Abstract][Full Text] [Related]
39. [A case of AFP-producing cholangiocarcinoma with difficulty in differential diagnosis from hepatocellular carcinoma].
Omori J; Niimi A; Furuichi Y; Takeuchi E; Ishikawa T; Yanagisawa A; Ogihara S; Tsuchiya M; Misaka R; Shigemoto M; Kurihara T; Maeda A; Yamashita K; Aratake T; Kameoka S; Nishikawa T
Nihon Shokakibyo Gakkai Zasshi; 2004 Oct; 101(10):1106-11. PubMed ID: 15529784
[No Abstract] [Full Text] [Related]
40. Differential expression of anterior gradient protein 3 in intrahepatic cholangiocarcinoma and hepatocellular carcinoma.
Brychtova V; Zampachova V; Hrstka R; Fabian P; Novak J; Hermanova M; Vojtesek B
Exp Mol Pathol; 2014 Jun; 96(3):375-81. PubMed ID: 24747240
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
